Advance NanoTek (ASX Code ANO) released their 2021 Annual Report today. In the FY22 Outlook statement they repeated that the COVID-19 recovery in sales is ongoing. Distributors are requesting their orders to be brought forward. Based on forecasts from distributors and firm orders placed to date, they anticipate that sales for this half will be similar to that of FY19 sales. They are positive that zinc based sunscreen growth will continue and their new ZinClear XP dispersions will generate additional sales in FY22.